2022 ACS共识会议摘要：在创伤中实施最佳静脉血栓栓塞症(VTE)预防

2022-12-19 美国外科医师协会 J Trauma Acute Care Surg 发表于上海

2022年5月4日至5日，国家创伤研究联盟(CNTR)召开了一次关于预防和治疗创伤后静脉血栓栓塞症(VTE)的多学科利益相关者会议。

中文标题：

英文标题：

Proceedings from the 2022 Consensus Conference to Implement Optimal Venous Thromboembolism (VTE) Prophylaxis in Trauma

发布机构：

美国外科医师协会

发布日期：

2022-12-19

简要介绍：

2022年5月4日至5日，国家创伤研究联盟(CNTR)召开了一次关于预防和治疗创伤后静脉血栓栓塞症(VTE)的多学科利益相关者会议，该会议由美国国立卫生研究院(NIH/NHLBI)的国家心肺和血液研究所(NIH/NHLBI)资助，并由位于伊利诺伊州芝加哥的美国外科医生学会(ACS)主办。这次共识会议聚集了40多名面对面的与会者和80多名虚拟与会者，包括创伤外科医生、其他医生、血栓形成专家、护士、药剂师、研究人员和患者权益倡导者。会议的目的有两个：1)审查和总结有关受伤患者VTE预防策略的科学证据的现状，2)就VTE预防实施的未来优先事项和研究差距达成共识。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=7b1281c0028e21a3, title=2022 ACS共识会议摘要：在创伤中实施最佳静脉血栓栓塞症(VTE)预防, enTitle=Proceedings from the 2022 Consensus Conference to Implement Optimal Venous Thromboembolism (VTE) Prophylaxis in Trauma, guiderFrom=J Trauma Acute Care Surg, authorId=0, author=, summary=2022年5月4日至5日，国家创伤研究联盟(CNTR)召开了一次关于预防和治疗创伤后静脉血栓栓塞症(VTE)的多学科利益相关者会议。, cover=https://img.medsci.cn/Random/atrial-fibrillation-s18-photo-of-operating-room.jpg, journalId=0, articlesId=null, associationId=654, associationName=美国外科医师协会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Dec 19 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p>2022年5月4日至5日，国家创伤研究联盟(CNTR)召开了一次关于预防和治疗创伤后静脉血栓栓塞症(VTE)的多学科利益相关者会议，该会议由美国国立卫生研究院(NIH/NHLBI)的国家心肺和血液研究所(NIH/NHLBI)资助，并由位于伊利诺伊州芝加哥的美国外科医生学会(ACS)主办。这次共识会议聚集了40多名面对面的与会者和80多名虚拟与会者，包括创伤外科医生、其他医生、血栓形成专家、护士、药剂师、研究人员和患者权益倡导者。会议的目的有两个：1)审查和总结有关受伤患者VTE预防策略的科学证据的现状，2)就VTE预防实施的未来优先事项和研究差距达成共识。</p>, tagList=[TagDto(tagId=8617, tagName=VTE), TagDto(tagId=63202, tagName=创伤后VTE)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=8617, articleKeyword=VTE, articleKeywordNum=6, guiderKeywordId=8617, guiderKeyword=VTE, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6179, appHits=144, showAppHits=0, pcHits=499, showPcHits=6035, likes=0, shares=12, comments=4, approvalStatus=1, publishedTime=Fri Dec 23 16:09:00 CST 2022, publishedTimeString=2022-12-19, pcVisible=1, appVisible=1, editorId=0, editor=lixiang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=lixiang, createdTime=Tue Dec 20 12:12:33 CST 2022, updatedBy=6459136, updatedName=玉在山, updatedTime=Thu Jan 04 16:53:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=Proceedings_from_the_2022_Consensus_Conference_to.230.pdf)])

Proceedings_from_the_2022_Consensus_Conference_to.230.pdf

下载请点击：

评论区 (3)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2138207, encodeId=faf1213820ea7, content=积分？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6038710072, createdName=ms5000000022127174, createdTime=Sun May 21 16:22:43 CST 2023, time=2023-05-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107844, encodeId=fa4f210e8443d, content=积分？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221228/d1104f6542e44c608e06b8e54aba0443/f3d477d40b754472b06145e72422411b.png, createdBy=7bb88381161, createdName=张乐Zl, createdTime=Wed Dec 28 15:39:07 CST 2022, time=2022-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107226, encodeId=8f81210e226ee, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/14/185629059ff740bf3c8e770a62c113a5.jpg, createdBy=51102023282, createdName=顾阳, createdTime=Fri Dec 23 23:38:23 CST 2022, time=2022-12-23, status=1, ipAttribution=新疆)]
2023-05-21 ms5000000022127174 来自辽宁省

积分？

28 0
[GetPortalCommentsPageByObjectIdResponse(id=2138207, encodeId=faf1213820ea7, content=积分？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6038710072, createdName=ms5000000022127174, createdTime=Sun May 21 16:22:43 CST 2023, time=2023-05-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107844, encodeId=fa4f210e8443d, content=积分？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221228/d1104f6542e44c608e06b8e54aba0443/f3d477d40b754472b06145e72422411b.png, createdBy=7bb88381161, createdName=张乐Zl, createdTime=Wed Dec 28 15:39:07 CST 2022, time=2022-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107226, encodeId=8f81210e226ee, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/14/185629059ff740bf3c8e770a62c113a5.jpg, createdBy=51102023282, createdName=顾阳, createdTime=Fri Dec 23 23:38:23 CST 2022, time=2022-12-23, status=1, ipAttribution=新疆)]
2022-12-28 张乐Zl 来自广东省

积分？

41 0
[GetPortalCommentsPageByObjectIdResponse(id=2138207, encodeId=faf1213820ea7, content=积分？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6038710072, createdName=ms5000000022127174, createdTime=Sun May 21 16:22:43 CST 2023, time=2023-05-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2107844, encodeId=fa4f210e8443d, content=积分？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221228/d1104f6542e44c608e06b8e54aba0443/f3d477d40b754472b06145e72422411b.png, createdBy=7bb88381161, createdName=张乐Zl, createdTime=Wed Dec 28 15:39:07 CST 2022, time=2022-12-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2107226, encodeId=8f81210e226ee, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/14/185629059ff740bf3c8e770a62c113a5.jpg, createdBy=51102023282, createdName=顾阳, createdTime=Fri Dec 23 23:38:23 CST 2022, time=2022-12-23, status=1, ipAttribution=新疆)]
2022-12-23 顾阳来自新疆

打卡

57 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

骨科指南

2022 ACS共识会议摘要：在创伤中实施最佳静脉血栓栓塞症(VTE)预防

相关指南

拓展阅读

科室

工具

服务